Search research articles
Contact Us
Filters
Showing results (131-140 of 185) with videos related to
Page
of 19
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 3, 2000
Treatment of brain metastases of small-cell lung cancer: comparing teniposide and teniposide with whole-brain radiotherapy--a phase III study of the European Organization for the Research and Treatment of Cancer Lung Cancer Cooperative Group
P E Postmus, H Haaxma-Reiche, E F Smit, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 28, 2004
Combination therapy with gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, gemcitabine and cisplatin in patients with advanced solid tumors
G Giaccone, J L González-Larriba, A T van Oosterom, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology
|
September 18, 2009
A panel of high resolution melting (HRM) technology-based assays with direct sequencing possibility for effective mutation screening of EGFR and K-ras genes
D A M Heideman, F B Thunnissen, M Doeleman, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 8, 2004
Critical factors for patient management
V Ninane, C Le Pechoux, W Curran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Gemcitabine and paclitaxel: pharmacokinetic and pharmacodynamic interactions in patients with non-small-cell lung cancer
J R Kroep, G Giaccone, D A Voorn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 8, 2016
Pemetrexed plus carboplatin versus pemetrexed in pretreated patients with advanced non-squamous non-small-cell lung cancer: treating the right patients based on individualized treatment effect prediction
R C M van Kruijsdijk, F L J Visseren, L Boni, et al.
ESMO Open
|
November 21, 2025
First-in-human study of a thorium-227-labeled mesothelin-targeting antibody-chelator conjugate (MSLN-TTC), in patients with malignant mesothelioma and other solid tumors
A Minchom, O Lindén, D G Knapen, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 1, 2025
Liquid biopsy in BALF is now suitable for clinical practice in patients with suspected NSCLC
F J Borm, M J Schelhaas, E M P Steeghs, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 17, 2005
Expression of the p16(INK4a) gene product, methylation of the p16(INK4a) promoter region and expression of the polycomb-group gene BMI-1 in squamous cell lung carcinoma and premalignant endobronchial lesions
R H J Breuer, P J F Snijders, G T Sutedja, et al.
Lung Cancer (Amsterdam, Netherlands)
|
June 16, 2019
The prognostic value of early onset, CT derived loss of muscle and adipose tissue during chemotherapy in metastatic non-small cell lung cancer
J H R J Degens, K J C Sanders, E E C de Jong, et al.
Page
of 19
Search research articles
Search
Showing results (131-140 of 185) with videos related to
Sort By:
Page
of 19
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 3, 2000
Treatment of brain metastases of small-cell lung cancer: comparing teniposide and teniposide with whole-brain radiotherapy--a phase III study of the European Organization for the Research and Treatment of Cancer Lung Cancer Cooperative Group
P E Postmus, H Haaxma-Reiche, E F Smit, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 28, 2004
Combination therapy with gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, gemcitabine and cisplatin in patients with advanced solid tumors
G Giaccone, J L González-Larriba, A T van Oosterom, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology
|
September 18, 2009
A panel of high resolution melting (HRM) technology-based assays with direct sequencing possibility for effective mutation screening of EGFR and K-ras genes
D A M Heideman, F B Thunnissen, M Doeleman, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 8, 2004
Critical factors for patient management
V Ninane, C Le Pechoux, W Curran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Gemcitabine and paclitaxel: pharmacokinetic and pharmacodynamic interactions in patients with non-small-cell lung cancer
J R Kroep, G Giaccone, D A Voorn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 8, 2016
Pemetrexed plus carboplatin versus pemetrexed in pretreated patients with advanced non-squamous non-small-cell lung cancer: treating the right patients based on individualized treatment effect prediction
R C M van Kruijsdijk, F L J Visseren, L Boni, et al.
ESMO Open
|
November 21, 2025
First-in-human study of a thorium-227-labeled mesothelin-targeting antibody-chelator conjugate (MSLN-TTC), in patients with malignant mesothelioma and other solid tumors
A Minchom, O Lindén, D G Knapen, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 1, 2025
Liquid biopsy in BALF is now suitable for clinical practice in patients with suspected NSCLC
F J Borm, M J Schelhaas, E M P Steeghs, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 17, 2005
Expression of the p16(INK4a) gene product, methylation of the p16(INK4a) promoter region and expression of the polycomb-group gene BMI-1 in squamous cell lung carcinoma and premalignant endobronchial lesions
R H J Breuer, P J F Snijders, G T Sutedja, et al.
Lung Cancer (Amsterdam, Netherlands)
|
June 16, 2019
The prognostic value of early onset, CT derived loss of muscle and adipose tissue during chemotherapy in metastatic non-small cell lung cancer
J H R J Degens, K J C Sanders, E E C de Jong, et al.
Page
of 19